Hollister Lecture to Focus on How Fight on Bioterrorism May Affect Individual Rights The 9/11 attacks and Anthrax scares that followed changed the world in every way including U.S. lawmakers’ and public health officials’ responses to bioterrorism. Furthering the dialog on how steps to fight bioterrorism may affect individuals and society as a whole, the[…]
October 1, 2002 New Protease Inhibitor Suppresses HIV Levels SAN DIEGO— A study from The Feinberg School of Medicine has shown that the protease inhibitor lopinavir/ritonavir (Kaletra®) suppressed HIV to undetectable levels and was well tolerated through four years of treatment in patients who had not previously received antiretroviral therapy. To date in the Kaletra®[…]
October 1, 2002 Contact: Megan Fellman at (847) 491-3115 or at fellman@northwestern.edu Key Discovery in Neurodegenerative Diseases EVANSTON, ILL.— Northwestern University scientists have made a key molecular discovery that has implications for a wide range of diseases characterized by the loss of nerve function, including Huntington’s, Parkinson’s, Alzheimer’s and Lou Gehrig’s diseases, cystic fibrosis, and[…]
September 30, 2002 Albrecht-Buehler Elected to European Academy CHICAGO— Guenter Albrecht-Buehler, Robert Laughlin Rea Professor of Anatomy and professor of cell and molecular biology at The Feinberg School of Medicine, has been elected a member of the European Academy of Sciences. Dr. Albrecht-Buehler was elected to the academy based on his “outstanding and lasting contribution[…]
Northwestern Remembers Harold Visotsky Friends, colleagues, and family members gathered September 25 in Northwestern Memorial Hospital’s Pritzker Auditorium to pay tribute to Harold M. Visotsky, MD, chair of the Department of Psychiatry and Behavioral Sciences at Northwestern’s medical school for 25 years. Dr. Visotsky, who died June 16 at age 78, also served as director[…]
September 18, 2002 Nocturnal Blood Pressure May Have Kidney Disease Link CHICAGO— Monitoring nighttime blood pressure is a simple, painless and noninvasive method of identifying patients with Type 1 diabetes who are at increased risk for kidney disease, according to a study published in the Sept. 12 issue of The New England Journal of Medicine[…]
September 9, 2002 Contact: Megan Fellman at (847) 491-3115 or at fellman@northwestern.edu “Fingerprints” for Biological Agents EVANSTON, ILL.— Scientists at Northwestern University have developed a powerful new method for detecting infectious diseases, including those associated with many bioterrorism and warfare threats such as anthrax, tularemia, smallpox, and HIV. A research team led by Chad A.[…]
Visit the Access to Essential Medicines EXPO Millions of people die each year from diseases for which medicines are too expensive, no longer effective, or out of production. Northwestern University’s Feinberg School of Medicine is one of 22 cities that the Access to Essential Medicines EXPO will visit this year to highlight this dearth of[…]
Entering Medical Students Don White Coats This year’s entering medical students have arrived from both coasts and everywhere in-between and beyond. The Class of 2006 was officially welcomed to Northwestern University’s Feinberg School of Medicine at the Founders’ Day Convocation on August 30. The annual event marked the 144th opening of the medical school academic[…]
August 7, 2002 Crohn’s Disease Therapies Tested CHICAGO— Researchers at The Feinberg School of Medicine at Northwestern University are conducting clinical trials of several innovative approaches to the treatment of Crohn’s disease, including experimental drugs and a new swallowable video camera that produces high-quality images of the small intestine. In addition to aiding diagnosis by[…]